Alfasigma

#ALSpotlights We renewed also this year our sponsorship with the European Venous Forum, participating to the 24th edition of the #EuropeanVenousForum Meeting 2024, in Athens from June 27th to 29th. It was an invaluable opportunity to share insights and new scientific evidence in the treatment of vascular diseases, with a focus on the management of chronic venous disease (CVD) and an update on practical phlebology. We are inspired by the collaborative spirit of the venous health community and look forward to continuing our work in improving patient outcomes. #AlfasigmaHealthHub #PharmaceuticalsWithPassion #EVF2024 

Today is #WorldMicrobiomeDay 2024! 🦠 In this occasion we celebrate the #gutmicrobiome and its crucial role in maintaining our overall health: from aiding digestion, supporting our immune system, and even influencing our mental well-being. This year's theme, "Feed your microbes - How diet shapes your gut microbiome", highlights the importance of nutrition in maintaining a healthy #microbiome. At #Alfasigma, we are committed to providing better therapeutic solutions to enhance the health and well-being of the microbiota. Swipe through the carousel to learn how diet impacts your gut health and discover tips to support your microbiome. #AlfasigmaHealthHub #PharmaceuticalsWithPassion #FeedYourMicrobes 

🚀  We are thrilled to announce that Alfasigma has been awarded the Best in Media Communication (BIC) certification, the first integrated system for measuring and enhancing media communication. This prestigious recognition, promoted by Fortune Italia and Eikon Strategic Consulting Italia, follows a rigorous audit based on scientific and objective criteria, evaluating reputation, media impact assessment, and media poll. Specifically, we were recognized for "International Transformation and Growth" as our Top Communication Value, reflecting our capacity to convey key messages about investments in our major transformation process, business #growth, and international market positioning. Thanks to Simona Gelpi, Alfasigma Corporate Communication & Institutional Relations Director, and her team for making this possible. #AlfasigmaHealthHub #PharmaceuticalWithPassion

Today starts the European Association for the Study of the Liver (#EASL) Congress in Milan, bringing together leading experts, researchers, and healthcare professionals from around the world. The event, featuring interactive learning sessions, symposia, debates, workshops, and ‘meet the expert’ sessions, will cover all topics related to #liverdisease. A unique opportunity for networking and engaging with the scientific community, fostering collaboration and knowledge exchange. #AlfasigmaHealthHub #PharmaceuticalsWithPassion #EASLCongress

#Italy Town Hall: connecting, inspiring, and leading together! On May 9th, the Opificio Golinelli in Bologna hosted our Italian Town Hall, with over 200 colleagues attending in person and more than 1500 joining online from across the country. Our leadership team, including Chairman Stefano Golinelli, CEO Francesco Balestrieri, Country Italy General Manager Marco Castino, Chief Technical Operations Officer Fabio Russo, Chief Human Resources Officer Anna Celleri and Corporate Communication & Institutional Relations Director Simona Gelpi, shared insightful updates on our strategy, projects, and priorities.   However, this Town Hall wasn't just about updates; it was about coming together, sharing our journey, and looking ahead to a future we are all building together.   Thank you to everyone who participated! #AlfasigmaHealthHub #PharmaceuticalWithPassion

#ALSpotlights 📅 On may 28th, our Chief Technical Operations Officer, Fabio Russo, participated at the European Pharma Outsourcing Summit 2024 in Berlin as a panelist in the roundtable “Maximising The Benefits Of Outsourcing Through An Effective Network Strategy”.   Providing pharmaceutical executives with current trends, strategic insights and best practices, the summit represented a valuable opportunity to meet and discuss with international peers and leaders in manufacturing, quality, procurement and supply chain.   Generis #AlfasigmaHealthHub #PharmaceuticalsWithPassion #GenerisPMOS #EUPharma24

🌍 Today is #WorldDigestiveHealthDay promoted by the World Gastroenterology Organisation (WGO) to raise awareness of the #prevention, prevalence, diagnosis, management, and treatment of #digestivediseases and disorders worldwide. The digestive system acts as the gateway to nourishment, absorbing vital nutrients necessary for sustaining bodily functions and promoting optimal health. As Alfasigma, we have always been at the forefront of gastroenterological health, confirming our commitment to supporting patients in this area. That’s why we proudly joins this year’s campaign, "Your Digestive Health: Make It A Priority." By making digestive health a priority and recognizing the pivotal role of the digestive system in overall health, we foster a proactive approach to healthcare that not only enhances physical health but also contributes to mental and emotional equilibrium. Let's make digestive health a priority for a healthier future! #AlfasigmaHealthHub #PharmaceuticalsWithPassion #WDHD2024 #YourDigestiveHealth

The annual edition of Digestive Disease Week® (DDW), one of the leading international events in the fields of gastroenterology has just concluded. It took place in Washington, D.C. from May 18th to 21st. For Alfasigma Group and Intercept Pharmaceuticals was a valuable occasion to engage with the scientific community, showcase the latest research and highlight the commitment to improve the lives of people affected by gastrointestinal and liver rare diseases. #AlfasigmaHealthHub #PharmaceuticalsWithPassion #DDW2024 

A major growth plan and a new governance. Alfasigma transforms in the name of innovation.   In L’Economia of Corriere della Sera, the Chairman and the CEO of Alfasigma, Stefano Golinelli and Francesco Balestrieri, discuss the company’s new strategy aimed at accelerating global growth, building a research pipeline, and expanding the commercial platform in key markets, with particular focus on the United States. #AlfasigmaHealthHub #PharmaceuticalsWithPassion

May 19th is #WorldIBDDay so we’d like to take this chance to talk about IBD and shed light on its profound impact worldwide! Inflammatory bowel disease (IBD) indicates two conditions – Crohn’s disease and ulcerative colitis – that are characterized by chronic inflammation of the gastrointestinal tract. The journey of an IBD patient is long and often fraught with challenges, from the initial symptoms to difficult diagnosis to the ongoing management of these conditions, with a burden of the disease that weighs heavily on patients affecting every aspect of their lives. At #Alfasigma, we believe that addressing IBD is not only about alleviating symptoms but also about restoring patients' quality of life. Recognizing the importance of early diagnosis, we can support timely interventions that are crucial for enabling patients to respond promptly to therapies and improve their overall well-being. We are proud to endorse the global campaign “IBD HAS NO BORDERS”, with the aim of raising awareness about the daily challenges of living with IBD! Swipe through the carousel to know more about it. #AlfasigmaHealthHub #PharmaceuticalsWithPassion #IBDHasNoBorders #WorldIBDDay2024